Celexion secures patent for the production of biobased difunctional alkanes
Friday March 23 2012
Celexion was recently granted a patent in USA for "Biological synthesis of difunctional alkanes from carbohydrate feedstocks." The patent covers biological methods for converting renewable feedstocks into a variety of high-value chemicals with a total market value of over $10 billion.
Dr. Brian M. Baynes, CEO of Celexion and co-inventor of the technology said "The methods disclosed in this patent enable a variety of important bulk chemicals to be synthesized from renewable starting materials using biological catalysts. The efficiency of this approach makes our products not only sustainable, but also less expensive than their petroleum-derived equivalents."
Please log in to read the rest of this article.
If you are not a subscriber, you can subscribe here
© Informa UK Limited. All rights reserved. Copyright contained in any part of this article is owned or and/or controlled by Informa UK Limited No part of the article may be reproduced, stored in a retrieval system, or transmitted in any form or by any means electronic, mechanical, photographic, recorded or otherwise without the prior written permission of Informa UK Limited though you may print or download the article (in whole or in part) for your personal and non-commercial use.